Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00225641

Recruitment Status : Unknown

Verified December 2015 by Peer Wille-Jørgensen, Bispebjerg Hospital.
Recruitment status was: Active, not recruiting

First Posted : September 26, 2005

Last Update Posted : December 22, 2015

Sponsor:

Collaborators:

Nordic Cancer Union

Danish Cancer Society

Danish Colorectal Cancer Group

Information provided by (Responsible Party):

Peer Wille-Jørgensen, Bispebjerg Hospital

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	December 2015
Estimated Study Completion Date :	December 2015

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Wille-Jørgensen P, Syk I, Smedh K, Laurberg S, Nielsen DT, Petersen SH, Renehan AG, Horváth-Puhó E, Påhlman L, Sørensen HT; COLOFOL Study Group. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial. JAMA. 2018 May 22;319(20):2095-2103. doi: 10.1001/jama.2018.5623.

To Top